Is a complete PRVA research report available?

No complete published report is available for Privia Health Group, Inc. (PRVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Privia Health Group, Inc. (PRVA)

NASDAQ: PRVA · USD

$21.8

-0.02 (-0.1%)· Recorded snapshot

Market cap	2.8B
Revenue (ttm)	2.4B
Net income (ttm)	28.1M
EPS (ttm)	$0.22
Shares out	127.7M
P/E (trailing)	99.5x
P/E (forward)	57.3x
Volume	482,300
Beta	0.80

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Metric	Value
Amount currency	USD
CIK code	0001759655
Company name	Privia Health Group, Inc.
Country	United States
Country code	US
CUSIP number	74276R102
Earnings date	2026-11-05
Earnings time	bmo
Employees	1,226
Employees change	86
Employees growth	7.54%
Enterprise value	$2.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2021-04-29
Is primary listing	Yes
Is SPAC	No
ISIN number	US74276R1023
Last 10-K release date	2026-02-27
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.8B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$21.81
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	PRVA
U.S. state	Virginia
Website	https://www.priviahealth.com

Metric

Value

Amount currency

USD

CIK code

0001759655

Company name

Privia Health Group, Inc.

Country

United States

Country code

CUSIP number

74276R102

Earnings date

2026-11-05

Earnings time

bmo

Employees

1,226

Employees change

Employees growth

7.54%

Enterprise value

$2.4B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2007

In index

RUSSELL2000

Industry

Health Information Services

IPO date

2021-04-29

Is primary listing

Yes

Is SPAC

ISIN number

US74276R1023

Last 10-K release date

2026-02-27

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.8B

Market cap category

Mid-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$21.81

Price currency

USD

Sector

Healthcare

SIC code

8000

Stock price date

2026-10-28

Symbol

PRVA

U.S. state

Virginia

Website

https://www.priviahealth.com

Metric	Value
Adjusted P/E ratio	23.71x
Average P/E ratio (3Y)	139.53x
Average P/E ratio (5Y)	139.9x
Earnings yield	1.01%
EV/Earnings	85.39x
EV/EBIT	53.52x
EV/EBITDA	42.18x
EV/FCF	18.31x
EV/Sales	1.02x
FCF / EV yield	5.46%
FCF yield	4.67%
Forward EV/Sales	0.94x
Forward P/E	57.29x
Forward P/S	1.1x
Graham number	5.52843
Graham upside	-74.83%
Industry forward P/E	34.62x
Lynch fair value	$1.10
Lynch upside	-95.01%
P/(FCF - SBC) ratio	50.65x
P/(OCF - SBC) ratio	50.65x
P/B ratio	3.52x
P/E ratio	99.46x
P/FCF ratio	21.39x
P/OCF ratio	21.39x
P/S ratio	1.19x
Price / tangible book value	8.06x
Price/EBITDA ratio	49.27x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

23.71x

Average P/E ratio (3Y)

139.53x

Average P/E ratio (5Y)

139.9x

Earnings yield

1.01%

EV/Earnings

85.39x

EV/EBIT

53.52x

EV/EBITDA

42.18x

EV/FCF

18.31x

EV/Sales

1.02x

FCF / EV yield

5.46%

FCF yield

4.67%

Forward EV/Sales

0.94x

Forward P/E

57.29x

Forward P/S

1.1x

Graham number

5.52843

Graham upside

-74.83%

Industry forward P/E

34.62x

Lynch fair value

$1.10

Lynch upside

-95.01%

P/(FCF - SBC) ratio

50.65x

P/(OCF - SBC) ratio

50.65x

P/B ratio

3.52x

P/E ratio

99.46x

P/FCF ratio

21.39x

P/OCF ratio

21.39x

P/S ratio

1.19x

Price / tangible book value

8.06x

Price/EBITDA ratio

49.27x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	1.9%
EBITDA margin	2.41%
Effective tax rate	39.69%
FCF margin	5.56%
Gross margin	10.03%
Operating margin	1.9%
Pretax margin	2.38%
Profit margin	1.19%
Profit per employee	$22,940
Profitable quarters	16
Profitable years	3
Revenue per employee	$1.9M
ROA	2.03%
ROA (5Y)	-4.85%
ROCE	5.25%
ROE	4.31%
ROE (5Y)	-11.26%
ROIC	6.52%
ROIC (5Y)	-30.26%
SBC / revenue	3.21%
Tax / revenue	0.94%

Metric

Value

EBIT margin

1.9%

EBITDA margin

2.41%

Effective tax rate

39.69%

FCF margin

5.56%

Gross margin

10.03%

Operating margin

1.9%

Pretax margin

2.38%

Profit margin

1.19%

Profit per employee

$22,940

Profitable quarters

Profitable years

Revenue per employee

$1.9M

ROA

2.03%

ROA (5Y)

-4.85%

ROCE

5.25%

ROE

4.31%

ROE (5Y)

-11.26%

ROIC

6.52%

ROIC (5Y)

-30.26%

SBC / revenue

3.21%

Tax / revenue

0.94%

Metric	Value
EPS growth	99.55%
EPS growth (Q)	250.01%
EPS growth (QoQ)	250%
EPS growth 3Y	-8.74%
EPS growth quarters	1
EPS growth years	1
FCF growth	42.75%
FCF growth (Q)	-86.2%
FCF growth 3Y	49.19%
FCF growth 5Y	28.99%
Gross profit growth	24.93%
Gross profit growth (Q)	24.97%
Gross profit growth 3Y	16.05%
Gross profit growth 5Y	32.68%
Net income growth	89.5%
Net income growth (Q)	236.73%
Net income growth (QoQ)	195.3%
Net income growth 3Y	-6.13%
Net income growth quarters	1
Net income growth years	1
OCF growth	42.75%
OCF growth (Q)	-86.2%
OCF growth 3Y	49.15%
OCF growth 5Y	28.85%
Operating income growth	128.78%
Operating income growth (Q)	252.91%
Operating income growth 3Y	58.04%
Revenue growth	24.1%
Revenue growth (Q)	21.39%
Revenue growth (QoQ)	4.77%
Revenue growth 3Y	16.1%
Revenue growth 5Y	22.35%
Revenue growth quarters	22
Revenue growth years	7

Metric

Value

EPS growth

99.55%

EPS growth (Q)

250.01%

EPS growth (QoQ)

250%

EPS growth 3Y

-8.74%

EPS growth quarters

EPS growth years

FCF growth

42.75%

FCF growth (Q)

-86.2%

FCF growth 3Y

49.19%

FCF growth 5Y

28.99%

Gross profit growth

24.93%

Gross profit growth (Q)

24.97%

Gross profit growth 3Y

16.05%

Gross profit growth 5Y

32.68%

Net income growth

89.5%

Net income growth (Q)

236.73%

Net income growth (QoQ)

195.3%

Net income growth 3Y

-6.13%

Net income growth quarters

Net income growth years

OCF growth

42.75%

OCF growth (Q)

-86.2%

OCF growth 3Y

49.15%

OCF growth 5Y

28.85%

Operating income growth

128.78%

Operating income growth (Q)

252.91%

Operating income growth 3Y

58.04%

Revenue growth

24.1%

Revenue growth (Q)

21.39%

Revenue growth (QoQ)

4.77%

Revenue growth 3Y

16.1%

Revenue growth 5Y

22.35%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$12.1M
EBIT	$44.9M
EBITDA	$56.9M
EPS	$0.22
FCF per share	$1.03
Financing cash flow	$-5.1M
Free cash flow	$131.1M
Free cash flow minus SBC	$55.4M
Gross profit	$236.5M
Income taxes	$22.3M
Investing cash flow	$-104M
Net cash flow	$22.1M
Net income	$28.1M
Operating cash flow minus SBC	$55.4M
Operating income	$44.9M
Revenue	$2.4B
Stock-based compensation	$75.7M

Metric

Value

Depreciation and amortization

$12.1M

EBIT

$44.9M

EBITDA

$56.9M

EPS

$0.22

FCF per share

$1.03

Financing cash flow

$-5.1M

Free cash flow

$131.1M

Free cash flow minus SBC

$55.4M

Gross profit

$236.5M

Income taxes

$22.3M

Investing cash flow

$-104M

Net cash flow

$22.1M

Net income

$28.1M

Operating cash flow minus SBC

$55.4M

Operating income

$44.9M

Revenue

$2.4B

Stock-based compensation

$75.7M

Metric	Value
Altman Z-Score	4.47
Book value per share	$6.19
Debt / EBITDA	0.14
Debt / equity	0.01
Debt / FCF	0.07
Goodwill	$215.8M
Long-term assets	$463.3M
Long-term liabilities	$16.1M
Net cash (debt)	$403.5M
Net cash / market cap	14.38%
Net cash growth	5.21%
Net debt / EBITDA	-7.09
Net debt / equity	-0.48
Net debt / FCF	-3.08
Piotroski F-Score	6
Property, plant and equipment	$8.3M
Shareholders' equity	$838.1M
Tangible book value	$347.9M
Tangible book value per share	$2.75
Total assets	$1.5B
Total cash	$412.2M
Total debt	$8.7M
Total liabilities	$650.5M
WACC	8.64%

Metric

Value

Altman Z-Score

4.47

Book value per share

$6.19

Debt / EBITDA

0.14

Debt / equity

0.01

Debt / FCF

0.07

Goodwill

$215.8M

Long-term assets

$463.3M

Long-term liabilities

$16.1M

Net cash (debt)

$403.5M

Net cash / market cap

14.38%

Net cash growth

5.21%

Net debt / EBITDA

-7.09

Net debt / equity

-0.48

Net debt / FCF

-3.08

Piotroski F-Score

Property, plant and equipment

$8.3M

Shareholders' equity

$838.1M

Tangible book value

$347.9M

Tangible book value per share

$2.75

Total assets

$1.5B

Total cash

$412.2M

Total debt

$8.7M

Total liabilities

$650.5M

WACC

8.64%

Metric	Value
Asset turnover	1.71
Current assets	$1B
Current liabilities	$634.4M
Current ratio	1.62
Net working capital	$-19.3M
Quick ratio	1.55
Working capital	$390.8M
Working capital turnover	6.38

Metric

Value

Asset turnover

1.71

Current assets

$1B

Current liabilities

$634.4M

Current ratio

1.62

Net working capital

$-19.3M

Quick ratio

1.55

Working capital

$390.8M

Working capital turnover

6.38

Metric	Value
Buyback yield / dilution	-2.73%
Dividend yield	0%
Shareholder yield	-2.73%

Metric

Value

Buyback yield / dilution

-2.73%

Dividend yield

Shareholder yield

-2.73%

Metric	Value
150-day SMA	$22.72
1D price change	-0.09%
1M price change	10.15%
1M total return	10.15%
1W price change	-5.32%
1W total return	-5.32%
1Y price change	-15.62%
1Y return CAGR	-15.63%
1Y total return	-15.62%
20-day SMA	$21.56
200-day SMA	$22.68
3M price change	-12%
3M total return	-12%
3Y price change	-0.55%
3Y return CAGR	-0.18%
3Y total return	-0.55%
50-day SMA	$20.86
50-day SMA vs 200-day SMA	50under200
52-week high	$28.82
52-week high date	2026-07-16
52-week low	$18.92
52-week low date	2026-09-24
5Y price change	-8.67%
5Y return CAGR	-1.8%
5Y total return	-8.67%
6M price change	-11.06%
6M total return	-11.06%
All-time high	$50.77
All-time high date	2021-06-29
All-time low	$15.92
All-time low date	2024-05-21
Average true range (ATR)	$0.61
Average volume	1.2M
Beta (1Y)	0.42
Beta (2Y)	0.67
Beta (5Y)	0.8
Change from 52-week high	-24.32%
Change from 52-week low	15.31%
Change from all-time high	-57.24%
Change from all-time low	36.37%
Change from open	-0.27%
Day's gap	0.18%
Dollar volume	$10.5M
High price	$21.96
Low price	$21.67
Monthly RSI	48.23
Open price	$21.87
Position in 52-week range	48.28%
Previous close	$21.83
Price vs 150-day SMA	-4.43%
Price vs 20-day SMA	0.71%
Price vs 200-day SMA	-4.27%
Price vs 50-day SMA	4.07%
Relative volume	0.41
Return from IPO open	-26.8%
Return from IPO price	-4.52%
RSI	52.35
Sharpe ratio	-0.5
Sharpe ratio (3Y)	0.06
Sharpe ratio (5Y)	0.09
Sortino ratio	-0.54
Sortino ratio (3Y)	0.25
Sortino ratio (5Y)	0.26
Volume	482.3K
Weekly RSI	47.81
YTD price change	-8.44%
YTD total return	-8.44%

Metric

Value

150-day SMA

$22.72

1D price change

-0.09%

1M price change

10.15%

1M total return

10.15%

1W price change

-5.32%

1W total return

-5.32%

1Y price change

-15.62%

1Y return CAGR

-15.63%

1Y total return

-15.62%

20-day SMA

$21.56

200-day SMA

$22.68

3M price change

-12%

3M total return

-12%

3Y price change

-0.55%

3Y return CAGR

-0.18%

3Y total return

-0.55%

50-day SMA

$20.86

50-day SMA vs 200-day SMA

50under200

52-week high

$28.82

52-week high date

2026-07-16

52-week low

$18.92

52-week low date

2026-09-24

5Y price change

-8.67%

5Y return CAGR

-1.8%

5Y total return

-8.67%

6M price change

-11.06%

6M total return

-11.06%

All-time high

$50.77

All-time high date

2021-06-29

All-time low

$15.92

All-time low date

2024-05-21

Average true range (ATR)

$0.61

Average volume

1.2M

Beta (1Y)

0.42

Beta (2Y)

0.67

Beta (5Y)

0.8

Change from 52-week high

-24.32%

Change from 52-week low

15.31%

Change from all-time high

-57.24%

Change from all-time low

36.37%

Change from open

-0.27%

Day's gap

0.18%

Dollar volume

$10.5M

High price

$21.96

Low price

$21.67

Monthly RSI

48.23

Open price

$21.87

Position in 52-week range

48.28%

Previous close

$21.83

Price vs 150-day SMA

-4.43%

Price vs 20-day SMA

0.71%

Price vs 200-day SMA

-4.27%

Price vs 50-day SMA

4.07%

Relative volume

0.41

Return from IPO open

-26.8%

Return from IPO price

-4.52%

RSI

52.35

Sharpe ratio

-0.5

Sharpe ratio (3Y)

0.06

Sharpe ratio (5Y)

0.09

Sortino ratio

-0.54

Sortino ratio (3Y)

0.25

Sortino ratio (5Y)

0.26

Volume

482.3K

Weekly RSI

47.81

YTD price change

-8.44%

YTD total return

-8.44%

Metric	Value
Float	108.9M
Float percentage	85.29%
Shares change (QoQ)	0.72%
Shares change (YoY)	2.73%
Shares held by insiders	0.49%
Shares held by institutions	81.43%
Shares outstanding	127.7M
Short % of float	5.33%
Short % of shares	4.55%
Short ratio	4.5 days

Metric

Value

Float

108.9M

Float percentage

85.29%

Shares change (QoQ)

0.72%

Shares change (YoY)

2.73%

Shares held by insiders

0.49%

Shares held by institutions

81.43%

Shares outstanding

127.7M

Short % of float

5.33%

Short % of shares

4.55%

Short ratio

4.5 days

Privia Health Group, Inc. (PRVA)

Price

Financial snapshot

Fair-value bridge

Latest news · PRVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PRVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PRVA

Frequently asked questions